Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 23, 2023 - Issue 8
Submit an article Journal homepage
1,508
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Is it possible to prevent relapse in panic disorder?

Rafael C. R. Freirea Department of Psychiatry, Faculty of Health Sciences, Queen’s University, Kingston, Canada;b Centre for Neuroscience Studies, Queen’s University, Kingston, Canada;c Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada;d Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3875-4601View further author information
ORCID Icon &
Antonio E. Nardid Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0002-2152-4669View further author information
ORCID Icon
Pages 677-679 | Received 01 May 2023, Accepted 22 Jun 2023, Published online: 26 Jun 2023

References

  • Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327–335. doi: 10.31887/DCNS.2015.17.3/bbandelow
  • Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1
  • Bandelow B, Allgulander C, Baldwin DS, et al. World federation of societies of biological psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: anxiety disorders. World J Biol Psychiatry. 2023;24(2):79–117. doi: 10.1080/15622975.2022.2086295
  • Batelaan NM, de Graaf R, Penninx BW, et al. The 2-year prognosis of panic episodes in the general population. Psychol Med. 2010;40(1):147–157. doi: 10.1017/S0033291709005625
  • Andersch S, Hetta J. A 15-year follow-up study of patients with panic disorder. Eur Psychiatry. 2003;18(8):401–408. doi: 10.1016/j.eurpsy.2003.03.007
  • Caldirola D, Alciati A, Dacco S, et al. Relapse prevention in panic disorder with pharmacotherapy: where are we now? Expert Opin Pharmacother. 2020;21(14):1699–1711. doi: 10.1080/14656566.2020.1779220.
  • Freire RC, Amrein R, Mochcovitch MD, et al. A 6-Year posttreatment follow-up of panic disorder patients: treatment with clonazepam predicts lower recurrence than treatment with paroxetine. J Clin Psychopharmacol. 2017;37(4):429–434. doi: 10.1097/JCP.0000000000000740
  • Rickels K, Schweizer E. Panic disorder: long-term pharmacotherapy and discontinuation. J Clin Psychopharmacol. 1998;18(6 Suppl 2):12S–18S. doi: 10.1097/00004714-199812001-00004
  • Nardi AE, Freire RC, Mochcovitch MD, et al. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. J Clin Psychopharmacol. 2012;32(1):120–126. doi: 10.1097/JCP.0b013e31823fe4bd
  • Levy HC, O’Bryan EM, Tolin DF. A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders. J Anxiety Disord. 2021;81:102407. doi: 10.1016/j.janxdis.2021.102407
  • Lorimer B, Kellett S, Nye A, et al. Predictors of relapse and recurrence following cognitive behavioural therapy for anxiety-related disorders: a systematic review. Cogn Behav Ther. 2021;50(1):1–18. doi: 10.1080/16506073.2020.1812709
  • Bandelow B, Sagebiel A, Belz M, et al. Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies. Br J Psychiatry. 2018;212(6):333–338. doi: 10.1192/bjp.2018.49
  • Bruce TJ, Spiegel DA, Hegel MT. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies. J Consult Clin Psychol. 1999;67(1):151–156. doi: 10.1037/0022-006X.67.1.151
  • Otto MW, McHugh RK, Simon NM, et al. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation. Behav Res Ther. 2010;48(8):720–727. doi: 10.1016/j.brat.2010.04.002
  • Takeshima M, Otsubo T, Funada D, et al. Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis. Psychiatry Clin Neurosci. 2021;75(4):119–127. doi: 10.1111/pcn.13195
  • Zugliani MM, Cabo MC, Nardi AE, et al. Pharmacological and neuromodulatory treatments for panic disorder: clinical trials from 2010 to 2018. Psychiatry Investig. 2019;16(1):50–58. doi: 10.30773/pi.2018.12.21.1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.